The official blog of the Lung Institute.

Rheumatoid Arthritis and Lung Disease

8 Apr 2015
| Under Lung Disease, Related Conditions | Posted by | 3 Comments
Rheumatoid Arthritis and Lung Disease Lung Institute

What is Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is an autoimmune disease in which your body’s immune system mistakenly attacks your joints. Autoimmune diseases, as a whole, cause the body’s immune system to mistake its own tissues for foreign invaders such as bacteria or viruses. At this point, the confused immune system develops antibodies that go out to search and destroy these so-called invaders; unfortunately, in the case of rheumatoid arthritis, these invaders are your own synovial tissues.

Rheumatoid arthritis causes chronic swelling and pain. Notable symptoms include pain, fatigue and warm, swollen, reddish joints. Many sufferers deal with long periods of joint stiffness in the morning and inflammation in the small joints of the wrist and hand.

Facts about Rheumatoid Arthritis

  • There are approximately 5 million Americans with rheumatoid arthritis.
  • Nearly three times as many women have rheumatoid arthritis than men.
  • Out of every 100,000 people, 41 are diagnosed with rheumatoid arthritis each year.
  • Rheumatoid arthritis can affect individuals of any age: Women are generally diagnosed between 30 and 60 years of age; men are usually diagnosed later in life; but even children can be diagnosed with the juvenile form of the disease.
  • The risk of a heart attack increases 60 percent one year after being diagnosed with rheumatoid arthritis.
  • People with rheumatoid arthritis are two times as likely to suffer from depression.
  • Rheumatoid arthritis typically costs sufferers around $5,763 per year.
  • Joints are not the only body part in danger; the lungs are often affected by rheumatoid arthritis resulting in interstitial lung disease or pulmonary fibrosis.

The Connection Between Rheumatoid Arthritis and Lung Disease

Rheumatoid arthritis-associated interstitial lung disease, or RA-ILD, is the most serious lung complication for sufferers of rheumatoid arthritis. This disease occurs when lung tissue becomes inflamed and scarred, which results in difficulty breathing, shortness of breath, coughing and wheezing.

The inflammation resulting from RA-ILD can often lead to pulmonary fibrosis—the permanent scarring of respiratory tissues. Interstitial lung disease and pulmonary fibrosis are both progressive lung diseases that currently don’t have a cure. But just because these diseases are incurable does not mean they are untreatable.

Stem cell therapy has proven effective for treating both pulmonary conditions like pulmonary fibrosis and interstitial lung disease and chronic conditions such as rheumatoid arthritis. Through stem cells innate healing properties and their ability to reduce inflammation, patients can get back to the life they once had.

If you or a loved one is dealing with the crippling effects of lung disease or rheumatoid arthritis, contact us at (800) 729-3065.


  1. pearlyon

    2 years ago

    I’m having trouble breathing. I’ve been diagnosed with reuehmatoid arthritis.

  2. Pingback: Lung Institute | The Impact of Stress on the Lungs

  3. Pingback: Lung Institute | Effects of Medication on Your Lungs

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.